NCT06676527 2025-12-05
Vorolanib in the Second-line Treatment of Patients With Unresectable or Metastatic Renal Cell Carcinoma
Jinling Hospital, China
Recruiting
Jinling Hospital, China
Instituto de Investigación Sanitaria de la Fundación Jiménez DÃaz